• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同程度动脉粥样硬化患者的D-二聚体与纤维蛋白溶解

D-dimer and fibrinolysis in patients with various degrees of atherosclerosis.

作者信息

Panchenko E, Dobrovolsky A, Davletov K, Titaeva E, Kravets A, Podinovskaya J, Karpov Y

机构信息

Department of Angiology, Cardiology Research Center RAMS, Moscow, Russia.

出版信息

Eur Heart J. 1995 Jan;16(1):38-42. doi: 10.1093/eurheartj/16.1.38.

DOI:10.1093/eurheartj/16.1.38
PMID:7737219
Abstract

D-dimer, plasminogen activator inhibitor (PAI-1) activity at rest and after exercise, and tissue plasminogen activator (t-PA) activity after exercise were measured in venous blood in 88 patients with atherosclerotic lesions of various degrees. According to clinical symptoms, coronary angiography (CAG), ultrasound Doppler signal and duplex and colour Doppler scanning of carotid arteries and their branches, subclavian, vertebral and peripheral arteries of the lower limbs, patients were divided into four groups. Group 1, 16 men without CAG and ultrasound signs of atherosclerotic lesions; group 2, 27 patients with CAG-confirmed coronary artery disease; group 3, 18 patients with peripheral artery occlusive disease; group 4, 27 patients with coexistence of two or more regions of atherosclerotic lesions. D-dimer was the highest in patients with the most extensive atherosclerosis: 432 +/- 164 ng.ml-1 in group 3, 429 +/- 98 ng.ml-1 in group 4 vs 163 +/- 25 ng.ml-1 in group 1, P < 0.05. There were correlations (P < 0.05) between: age and D-dimer (r = 0.29); D-dimer and t-PA (r = 0.34); D-dimer and PAI-1, r = -0.29. Patients were also analysed according to D-dimer level. In patients with the highest level of D-dimer, the lowest level of PAI-1 activity and the highest level of t-PA activity after exercise were observed. The low PAI-1 activity is probably the result of an increased release of t-PA in these patients.

摘要

对88例患有不同程度动脉粥样硬化病变的患者,检测其静息及运动后静脉血中的D-二聚体、纤溶酶原激活物抑制剂(PAI-1)活性以及运动后组织型纤溶酶原激活物(t-PA)活性。根据临床症状、冠状动脉造影(CAG)、超声多普勒信号以及对颈动脉及其分支、锁骨下动脉、椎动脉和下肢外周动脉的双功及彩色多普勒扫描,将患者分为四组。第1组,16名男性,无CAG及动脉粥样硬化病变的超声征象;第2组,27例经CAG确诊的冠心病患者;第3组,18例外周动脉闭塞性疾病患者;第4组,27例存在两个或更多动脉粥样硬化病变区域的患者。D-二聚体在动脉粥样硬化最广泛的患者中最高:第3组为432±164 ng/ml,第4组为429±98 ng/ml,而第1组为163±25 ng/ml,P<0.05。年龄与D-二聚体之间(r = 0.29)、D-二聚体与t-PA之间(r = 0.34)、D-二聚体与PAI-1之间(r = -0.29)存在相关性(P<0.05)。还根据D-二聚体水平对患者进行了分析。在D-二聚体水平最高的患者中,观察到运动后PAI-1活性最低,t-PA活性最高。PAI-1活性低可能是这些患者中t-PA释放增加的结果。

相似文献

1
D-dimer and fibrinolysis in patients with various degrees of atherosclerosis.不同程度动脉粥样硬化患者的D-二聚体与纤维蛋白溶解
Eur Heart J. 1995 Jan;16(1):38-42. doi: 10.1093/eurheartj/16.1.38.
2
Fibrinolytic activity in peripheral atherosclerosis in the elderly.老年人外周动脉粥样硬化中的纤溶活性。
Thromb Haemost. 1999 Feb;81(2):275-80.
3
Physical exertion induces thrombin formation and fibrin degradation in patients with peripheral atherosclerosis.体力活动会诱导外周动脉粥样硬化患者体内凝血酶的形成和纤维蛋白降解。
Arterioscler Thromb Vasc Biol. 1998 Feb;18(2):244-9. doi: 10.1161/01.atv.18.2.244.
4
Type 2 Diabetes and Cardiovascular Factors Contrasted with Fibrinolysis Disorders in the Blood of Patients with Peripheral Arterial Disease.2 型糖尿病与心血管因素及纤溶系统障碍在周围动脉疾病患者血液中的对比。
Medicina (Kaunas). 2019 Jul 22;55(7):395. doi: 10.3390/medicina55070395.
5
Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease.冠状动脉疾病患者运动期间纤溶酶原激活物抑制剂1和组织型纤溶酶原激活物的变化。
Haemostasis. 1990;20(5):305-12. doi: 10.1159/000216142.
6
D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.心肌梗死后稳定型心绞痛患者中D-二聚体与动脉硬化严重程度的关系
Eur Heart J. 1999 Oct;20(20):1493-502. doi: 10.1053/euhj.1999.1519.
7
Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood.心脏手术中的纤维蛋白溶解。组织纤溶酶原激活物在动脉血和冠状窦血中的释放。
Eur J Cardiothorac Surg. 1994;8(6):324-30. doi: 10.1016/s1010-7940(05)80093-4.
8
Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).2 型糖尿病合并稳定型冠状动脉疾病患者不同年龄阶段纤溶酶原激活物抑制剂-1、组织型纤溶酶原激活物抗原、纤维蛋白原和 D-二聚体水平的比较(来自 BARI 2D 试验)。
Am J Cardiol. 2010 Jan 1;105(1):17-24. doi: 10.1016/j.amjcard.2009.08.643. Epub 2009 Nov 14.
9
[Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].[闭塞性动脉粥样硬化症和糖尿病大血管病变患者的纤溶酶原激活剂(组织型纤溶酶原激活剂和尿激酶型纤溶酶原激活剂)及其他纤溶参数]
Pol Merkur Lekarski. 2001 Nov;11(65):414-7.
10
Prospective double-arm study of fibrinolysis in surgical patients.外科患者纤溶作用的前瞻性双臂研究。
J Surg Res. 1998 Jan;74(1):96-101. doi: 10.1006/jsre.1997.5233.

引用本文的文献

1
The Use of Clot Strength as a Predictor of Thrombosis in Peripheral Artery Disease.使用血栓弹力图评估血栓弹力图强度预测外周动脉疾病血栓形成的价值
Ann Vasc Surg. 2024 Dec;109:273-283. doi: 10.1016/j.avsg.2024.06.041. Epub 2024 Jul 26.
2
Epidemiology of Peripheral Artery Disease and Polyvascular Disease.外周动脉疾病和多血管疾病的流行病学。
Circ Res. 2021 Jun 11;128(12):1818-1832. doi: 10.1161/CIRCRESAHA.121.318535. Epub 2021 Jun 10.
3
Fibrinolytic variables in postmenopausal women with unstable coronary artery disease.绝经后不稳定型冠状动脉疾病女性的纤溶变量
J Thromb Thrombolysis. 2001 Dec;12(3):217-23. doi: 10.1023/a:1015270907430.